Osteopore Limited Stock: price and insider trades · Australia
Osteopore Limited: what insiders have been doing
This page follows insider dealings at Osteopore Limited as filed with ASX. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
There has been no open-market purchase by an insider of Osteopore Limited for at least a year.
With 5 filings in twelve months, the company is more active than the median of 4 filings across the 1,605 companies we follow on the same exchange.
These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Financial data
as of FY 2025FY ended December 2025 · cache
- ●Executives0ASX
- ●Executives0ASX
- ●Executives0ASX
- ●Executives0ASX
- ●Executives0ASX
5 of 5 declarations
About Osteopore Limited
Osteopore Limited is an Australian Securities Exchange listed company focused on developing innovative solutions for bone regeneration. It specializes in the research and commercialization of biomedical products.
